Ironwood Pharmaceuticals Progresses Vascular and Fibrotic Disease Platform with Positive Top-Line Phase Ia Data on Soluble Guanylate Cyclase Stimulator IW-1701
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 3.57 +0.02 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.55 | 52 Week High | $16.89 | |||
| Open | $3.50 | 52 Week Low | $7.35 | |||
| Day High | $3.61 | P/E | N/A | |||
| Day Low | $3.49 | EPS | $-2.35 | |||
| Volume | 1,041,087 | |||||
